David A. Barbie

Also affiliated with Harvard University, Dana-Farber Cancer Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 52 papers. Top paper: “Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status”.

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.10.013

N/A

8.9DataRank · unranked

377 citations

Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong +28 more

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

Inactivation of Fbxw7 Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1416

N/A

2.7DataRank · unranked

71 citations

David Liu, Diana Miao, Bart Lutterbach, Alexander L. DeVine, Chenyu Lin +19 more

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Journal of Clinical Investigation(2020)10.1172/jci135038

N/A

1.9DataRank · unranked

75 citations

Andrew Portell, Elena V. Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan Greene +23 more

Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9507

N/A

1.5DataRank · unranked

39 citations

Daniel B. Costa, Cloud P. Paweletz, Mark M. Awad, Paul Marcoux, Deepa Rangachari +13 more

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

JCO Precision Oncology(2020)10.1200/po.20.00121

N/A

1.5DataRank · unranked

29 citations

Evan W. Clark, Marina S.D. Milan, Christine Champagne, Kesi Michael, Mark M. Awad +10 more

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer

Nature Cancer(2023)10.1038/s43018-023-00591-2

N/A

1.4DataRank · unranked

42 citations

Enrico Patrucco, Cristina Mastini, Navin R. Mahadevan, Tran C. Thai, Elisa Bergaggio +26 more

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Nature Communications(2024)10.1038/s41467-024-51156-5

N/A

0.928DataRank · unranked

62 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway

Cancer Cell(2020)10.1016/j.ccell.2019.12.006

N/A

0.925DataRank · unranked

477 citations

Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan, Amir Vajdi +39 more

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

Cancer Discovery(2021)10.1158/2159-8290.cd-20-0913

N/A

0.809DataRank · unranked

219 citations

Erik H. Knelson, Jacquelyn O. Wolff, Amir Vajdi, Maria Saigí, Marco Campisi +38 more

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.07.005

N/A

0.701DataRank · unranked

106 citations

Joao V. Alessi, Arielle Elkrief, Xinan Wang, Alessio Cortellini, Y Y Li +27 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1844

N/A

0.564DataRank · unranked

42 citations

Mari Kuraguchi, Man Xu, Andrew Portell, Luke J. Taus, Irmina Diala +17 more

Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma

Annals of Oncology(2023)10.1016/j.annonc.2023.04.514

N/A

0.510DataRank · unranked

29 citations

Christine Lydon, Emily S. Chambers, Lynette M. Sholl, Mizuki Nishino, Ferdinandos Skoulidis +8 more

EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0171

N/A

0.500DataRank · unranked

27 citations

Dinesh Thapa, Anita Giobbie‐Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol +7 more

Preclinical models for development of immune–oncology therapies

Immuno Oncology Insights(2022)10.18609/ioi.2022.41

N/A

0.396DataRank · unranked

13 citations

Sarah E. Shelton, Gabriella Kastrunes, David A. Barbie, Gordon J. Freeman, Wayne A. Marasco +1 more

Integration of multiomic annotation data to prioritize and characterize inflammation and immune‐related risk variants in squamous cell lung cancer

Genetic Epidemiology(2020)10.1002/gepi.22358

N/A

0.357DataRank · unranked

8 citations

Miao Xu, Xihao Li, Sheila M. Gaynor, Hufeng Zhou, Zilin Li +46 more

The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells

Communications Biology(2023)10.1038/s42003-023-04444-7

N/A

0.330DataRank · unranked

8 citations

Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac +12 more

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

Cancers(2023)10.3390/cancers15164128

N/A

0DataRank · unranked

8 citations

Allen Green, Marco Campisi, Minyue Chen, Iliana Gjeci, Navin R. Mahadevan +15 more

Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.28.568627

N/A

0DataRank · unranked

4 citations

Nadia Gurvich, Mark R. Gillrie, Giovanni S. Offeddu, Mouhita Humayun, Ellen L. Kan +10 more

Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

(2023)10.1158/0008-5472.c.6514215.v1

N/A

0DataRank · unranked

0 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Data from Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer

(2023)10.1158/0008-5472.c.6513738.v1

N/A

0DataRank · unranked

0 citations

Erik H. Knelson, Yixiang Li, Yavuz T. Durmaz, Wenhua Gao, Emily Walton +14 more

Data from MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

(2023)10.1158/0008-5472.c.6514215

N/A

0DataRank · unranked

0 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Data from A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing

(2023)10.1158/2326-6066.c.6549088.v1

N/A

0DataRank · unranked

0 citations

Ruey‐Long Hong, Troy A. Luster, Megan E. Cavanaugh, Luke J. Taus, Stephen Wang +14 more

Non-pathogenic E. coli displaying decoy-resistant IL18 mutein boosts anti-tumor and CAR NK cell responses

Nature Biotechnology(2024)10.1038/s41587-024-02418-6

N/A

0DataRank · unranked

55 citations

Michal Sheffer, Isabel E. Kaplan, Zongqi Wang, Mubin Tarannum, Khanhlinh Dinh +24 more

Patient-specific vascularized tumor model: Blocking monocyte recruitment with multispecific antibodies targeting CCR2 and CSF-1R

Biomaterials(2024)10.1016/j.biomaterials.2024.122731

N/A

0DataRank · unranked

40 citations

Ellen L. Kan, Mouhita Humayun, Nadia Gurvich, Giovanni S. Offeddu, Zhengpeng Wan +13 more

Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0466

N/A

0DataRank · unranked

32 citations

Catherine B. Meador, Xintao Qiu, Ji-Heui Seo, Matthew P. Davidsohn, Hunter Savignano +20 more

Transmural Flow Upregulates PD‐L1 Expression in Microvascular Networks

Advanced Science(2024)10.1002/advs.202400921

N/A

0DataRank · unranked

8 citations

Shun Zhang, Amy X. Zhong, Liling Xu, Mark F. Coughlin, Georgios Pavlou +9 more

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Research Square(2024)10.21203/rs.3.rs-3935288/v1

N/A

0DataRank · unranked

4 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more

Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapy

Research Square(2024)10.21203/rs.3.rs-4031911/v1

N/A

0DataRank · unranked

3 citations

Shaobo Yang, Michal Sheffer, Isabel Kaplan, Zongqi Wang, Mubin Tarannum +22 more

Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes

Research Square(2024)10.21203/rs.3.rs-3935288/v2

N/A

0DataRank · unranked

2 citations

Adam Presser, Richa Singh, Matthew A. Booker, Nicole A. Traphagen, Kenny Weng +15 more

miR126-mediated impaired vascular integrity in Rett syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.11.617929

N/A

0DataRank · unranked

1 citations

Zhengpeng Wan, Koji Haratani, Ylliah Jin, Marco Campisi, David A. Barbie +3 more

Targeting STING to generate therapeutic anti-tumor immunity

Cancer Cell(2025)10.1016/j.ccell.2025.12.002

N/A

0DataRank · unranked

16 citations

Anthony F. Cordova, Patrick C. Gedeon, David A. Barbie, Caroline G. Fahey

Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102198

N/A

0DataRank · unranked

4 citations

Zehua Li, Jessica Ritter, Elliott J. Brea, Navin R. Mahadevan, Deborah Dillon +17 more

Myofibroblasts reduce angiogenesis and vasculogenesis in a vascularized microphysiological model of lung fibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.10.632378

N/A

0DataRank · unranked

2 citations

Adriana Blazeski, Eunkyung Ko, Tran C. Thai, Shania Dantes, David A. Barbie +3 more

Engineering approaches for studying immune-tumor cell interactions and immunotherapy

iScience(2020)10.1016/j.isci.2020.101985

N/A

0DataRank · unranked

92 citations

Huu Tuan Nguyen, David A. Barbie, Roger D. Kamm, Sarah E. Shelton

Tumor-Derived cGAMP Regulates Activation of the Vasculature

Frontiers in Immunology(2020)10.3389/fimmu.2020.02090

N/A

0DataRank · unranked

61 citations

Shriram K. Sundararaman, Sarah E. Shelton, Erik H. Knelson, Navin R. Mahadevan, Ryohei Yoshida +15 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0DataRank · unranked

241 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1991

N/A

0DataRank · unranked

42 citations

Erik H. Knelson, Yixiang Li, Yavuz T. Durmaz, Wenhua Gao, Emily Walton +14 more

KRAS G12C inhibition and innate immune targeting

Expert Opinion on Therapeutic Targets(2021)10.1080/14728222.2021.1902991

N/A

0DataRank · unranked

9 citations

Shunsuke Kitajima, Ella B. Conway, Erik H. Knelson, David A. Barbie, Tetsuo Tani

Regulation of Neuroendocrine Plasticity by the RNA-Binding Protein ZFP36L1

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.22.465501

N/A

0DataRank · unranked

4 citations

Yavuz T. Durmaz, Yixiang Li, Amin H. Sabet, Amir Vajdi, Thomas Denize +11 more

STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2111003119

N/A

0DataRank · unranked

171 citations

Erik H. Knelson, Jorge L. Jimenez-Macias, Michal O. Nowicki, Saemi Han, Eleni Panagioti +10 more

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.08.015

N/A

0DataRank · unranked

102 citations

Tetsuo Tani, Benjamin F. Springer, Marco Campisi, Tatsuya Osaki, Koji Haratani +23 more

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes

Nature Cancer(2022)10.1038/s43018-022-00427-5

N/A

0DataRank · unranked

90 citations

Sanjukta Das, Ângela C. Crespo, Annelisa M. Cornel, Anand G. Patel, Navin R. Mahadevan +24 more

Activation of Tumor-Cell STING Primes NK-Cell Therapy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0017

N/A

0DataRank · unranked

89 citations

Elena V. Ivanova, Mubin Tarannum, Marco Campisi, Patrick H. Lizotte, Matthew A. Booker +44 more

Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1

Nature Communications(2022)10.1038/s41467-022-31998-7

N/A

0DataRank · unranked

42 citations

Yavuz T. Durmaz, Yixiang Li, Amin H. Sabet, Amir Vajdi, Thomas Denize +12 more

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-0770

N/A

0DataRank · unranked

39 citations

Maria Saigí, Tetsuo Tani, Benjamin F. Springer, Hirofumi Shibata, Shunsuke Kitajima +19 more

Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer Immunotherapies

Cancers(2022)10.3390/cancers14153561

N/A

0DataRank · unranked

21 citations

Sarah E. Shelton, Minyue Chen, Roger D. Kamm, David A. Barbie, Erik H. Knelson +1 more

STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.28.481908

N/A

0DataRank · unranked

13 citations

Erik H. Knelson, Jorge L. Jimenez-Macias, Michal O. Nowicki, Saemi Han, Eleni Panagioti +10 more

Single-cell functional genomics of natural killer cell evasion in blood cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.22.504722

N/A

0DataRank · unranked

3 citations

Sara Gandolfi, Jani Huuhtanen, Olga Dashevsky, Khalid Saeed, Jay Klievink +26 more

The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.22.489111

N/A

0DataRank · unranked

2 citations

Shunsuke Kitajima, Fengkai Li, Yusuke Suita, Saradha Miriyala, Shakson Isaac +12 more

Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors

Nature Communications(2023)10.1038/s41467-023-37807-z

N/A

0DataRank · unranked

22 citations

Swetha Anandh, Jamie L. Null, Piotr Przanowski, Sanchita Bhatnagar, Pankaj Kumar +7 more